USFDA concludes inspection of Unichem Lab's Roha facility The United States Food and Drug Administration (USFDA) conducted inspection at the company's active pharmaceutical ingredients facility at Roha from September 9-12, 2019.
USFDA issues one observation for Unichem's Ghaziabad formulations facility "The United States Food and Drug Administration (USFDA) conducted inspection at the company's Ghaziabad formulation facility between August 19, 2019 to August 23, 2019. The inspection was a routine Good manufacturing practice (GMP) surveillance," Unichem said in a regulatory filing.
Unichem Lab gets USFDA nod for pain management drug The company has received abbreviated new drug application (ANDA) approval from the US Food and Drug Administration (USFDA) for Unichem’s Tramadol Hydrochloride tablets USP, in the strength 50 mg, Unichem Laboratories said in a regulatory filing on Tuesday.
Stocks in the news: RIL, Tata Motors, ONGC, BHEL, BPCL, Sintex Plastics, Varroc Engg, Oil India Tata Motors | Alembic | Bosch | National Aluminium Company | Unichem Laboratories | ONGC | BHEL | BPCL and Sintex Plastics are among stocks, which are in news today.
Stocks in the news: Zee Entertainment, Eicher Motors, Wipro, Ashok Leyland, HDFC Eicher Motors | Wipro | Ashok Leyland | IndiaMart InterMesh | Unichem Labs and Ajanta Pharma are stocks which are in the news today.
Stocks in the news: Zee Entertainment, Eicher Motors, Wipro, Ashok Leyland, IndiaMart Eicher Motors | Wipro | Ashok Leyland | IndiaMart InterMesh | Unichem Labs and Ajanta Pharma are stocks which are in the news today.
Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules, NHPC Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.